Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

HIF-1α is important for hair growth and could be a treatment target for hair loss.

New compounds may help treat prostate issues without affecting androgen receptors.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Key proteins and potential drugs for treating alopecia areata were identified.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

The Hr protein binds to DNA, interacts with p53, and affects cell cycle genes.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

New compounds show promise as nonsteroidal treatments for hair loss.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib may help treat severe hair loss, but more research is needed.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

New cytokine-targeted therapies show promise for treating alopecia areata.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.